This was evidenced, for example, by greater expression of TIMP3, an inhibitor of extracellular matrix degradation, and CHI3L1, a secreted glycoprotein also thought to drive tissue remodelling and a known genetic risk factor for asthma severity [19]. The gene discussed is CHI3L1; the disease is asthma.